News

Filter

Current filters:

Abbott Laboratories

1 to 9 of 1832 results

European Commission clears Mylan acquisition of Abbott's European generics business

European Commission clears Mylan acquisition of Abbott's European generics business

29-01-2015

The European Commission has cleared the proposed acquisition of Abbott Laboratories’ non-US developed…

Abbott LaboratoriesEuropeGenericsMergers & AcquisitionsMylan

USA files suit against Omnicare for accepting kickbacks from Abbott

23-12-2014

The United States has filed a civil False Claims Act complaint against Omnicare alleging that it solicited…

Abbott LaboratoriesDepakoteLegalMarkets & MarketingNeurologicalOmnicarePharmaceuticalUSA

Mylan and Abbott amend terms of their $5.3 billion deal

Mylan and Abbott amend terms of their $5.3 billion deal

23-10-2014

US generic drugmaker Mylan and US drugmaker Abbott Laboratories have revised the pricing terms of their…

AbbottAbbott LaboratoriesGenericsMergers & AcquisitionsUSA

Abbott raises midpoint of EPS guidance and sees shares rise as quarterly profit exceeds forecast

Abbott raises midpoint of EPS guidance and sees shares rise as quarterly profit exceeds forecast

22-10-2014

Shares of US health care company Abbott Laboratories rose slightly in the premarket trading period following…

Abbott LaboratoriesFinancialPharmaceuticalUnited StatesUSA

Abbott Labs 2nd-quarter revenues rise 1.9%

Abbott Labs 2nd-quarter revenues rise 1.9%

17-07-2014

US health care company Abbott Laboratories, which since its spin-out of its research-based prescription…

Abbott LaboratoriesFinancialPharmaceutical

Abbott Labs sells branded generics business to Mylan in $5.3 billion deal

Abbott Labs sells branded generics business to Mylan in $5.3 billion deal

14-07-2014

Following a weekend of rumors and speculation, USA-based generics major Mylan and health care firm Abbott…

Abbott LaboratoriesAustraliaCanadaEuropeFinancialGenericsJapanMergers & AcquisitionsMylanNew Zealand

Abbott to acquire Russia’s Veropharm for up to $495 million

Abbott to acquire Russia’s Veropharm for up to $495 million

24-06-2014

US drugmaker Abbott yesterday confirmed it had reached a definitive agreement to acquire Veropharm, a…

Abbott LaboratoriesMergers & AcquisitionsPharmaceuticalProductionRussiaVeropharm

1 to 9 of 1832 results

COMPANY SPOTLIGHT

Menarini

Back to top